We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI Assistance Improves Breast-Cancer Screening by Reducing False Positives

By MedImaging International staff writers
Posted on 11 Apr 2024
Print article
Image: AI-assisted breast-cancer screening may reduce unnecessary testing (Photo courtesy of WUSTL)
Image: AI-assisted breast-cancer screening may reduce unnecessary testing (Photo courtesy of WUSTL)

Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing, which not only causes patient anxiety but also consumes valuable medical resources. Now, a new study has shown how artificial intelligence (AI) can improve the accuracy of breast cancer screening by minimizing these false positives without missing true positives.

The study by researchers at Washington University School of Medicine in St. Louis (St. Louis, MO, USA) and Whiterabbit.ai (Santa Clara, CA, USA) builds on their previous collaboration for the development of an AI algorithm to help radiologists assess breast density on mammograms for identifying people who stand to benefit from additional or alternative screening. That algorithm is marketed by Whiterabbit.ai as WRDensity after receiving clearance from the Food and Drug Administration (FDA) in 2020.

In the current study, the team developed an algorithm to identify normal mammograms with extremely high sensitivity. They went on to run a simulation on patient data to see what would have happened if all of the very low-risk mammograms were taken off the radiologists’ plates, allowing the doctors to focus on the more questionable scans. The results of this simulation indicated that such an approach would reduce the number of unnecessary patient callbacks for additional testing, yet maintain the same rate of cancer detection.

“At the end of the day, we believe in a world where the doctor is the superhero who finds cancer and helps patients navigate their journey ahead,” said Jason Su, co-founder and chief technology officer at Whiterabbit.ai. “The way AI systems can help is by being in a supporting role. By accurately assessing the negatives, it can help remove the hay from the haystack so doctors can find the needle more easily. This study demonstrates that AI can potentially be highly accurate in identifying negative exams. More importantly, the results showed that automating the detection of negatives may also lead to a tremendous benefit in the reduction of false positives without changing the cancer detection rate.”

Related Links:

Gold Member
Solid State Kv/Dose Multi-Sensor
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
FMT Radiographic Suite
AdvantagePlus ML1

Print article


Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.